Potential pitfall: Overlapping lung cancer and COVID-19 symptoms means that the message to patients about early diagnosis is negated by the messages necessary to control the COVID pandemic. Helpful hint: Consider the following action if a patient presents with...
Thursday 25th June 2020 Dr Ben Noble’s RCGP award-winning Cancer Maps is a popular interactive reference tool for GPs based on the NICE NG12 guideline; primarily, the tool is designed to be used during consultations to help clinicians assess possible cancer symptoms....
Thursday 25th June 2020 Dr Ben Noble’s RCGP award-winning Cancer Maps is a popular interactive reference tool for GPs based on the NICE NG12 guideline; primarily, the tool is designed to be used during consultations to help clinicians assess possible cancer symptoms....
Friday 19th June 2020 For many patients, the relief of surviving their treatment or managing their condition can be followed with questions about other aspects of their life. Impotence can be very common after treatment for colorectal cancer; often affecting up to 90%...
Friday 18th October 2019
The new Faecal Immunochemical Test (FIT) rolled out across England this year has a number of benefits in replacing the use of older guaiac-based faecal occult blood tests (gFOBTs). Is your practice up to date with the new processes associated with FIT and are you aware of the reasons for the change?
Our latest course on Faecal Immunochemical Testing (FIT) is now available, outlining the use of FIT as a screening tool and appropriate use for symptomatic patients. It also includes some of the key benefits of changing to this method from gFOBTs, including:
Find out more:
Find out more: visit the GatewayC Faecal Immunochemical Test course here. 1 CPD credit is available upon completion of this course.